--- title: 博客 | 附录一 description: 附录一 | --- [![Logo PQE Group - azzurro - 2024](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20PQE%20Group%20-%20azzurro%20-%202024.png?width=2000&height=721&name=Logo%20PQE%20Group%20-%20azzurro%20-%202024.png "Logo PQE Group - azzurro - 2024")](https://www2.pqegroup.com/cn/) - [主页](https://www2.pqegroup.com/cn/) - [行业](https://www2.pqegroup.com/cn/industry/) - [药品 & 活性成分](https://www2.pqegroup.com/cn/pharma-api/) - [医疗器械](https://www2.pqegroup.com/cn/medical-device/) - [生物技术](https://www2.pqegroup.com/cn/biotech/) - [初创企业](https://www2.pqegroup.com/cn/startup/) - [兽药](https://www2.pqegroup.com/cn/veterinary/) - [我们的服务](https://www2.pqegroup.com/cn/services/) - [数据完整性](https://www2.pqegroup.com/cn/data-integrity/) - [数字化管理](https://www2.pqegroup.com/cn/digital-governance/) - [工程](https://www2.pqegroup.com/cn/engineering/) - [调试、确认和验证 (CQV)](https://www2.pqegroup.com/cn/commissioning-qualification-validation/) - [质量合规](https://www2.pqegroup.com/cn/quality-compliance/) - [卓越实验室](https://www2.pqegroup.com/cn/laboratory-excellence/) - [药政事务](https://www2.pqegroup.com/cn/regulatory-affairs/) - [审计](https://www2.pqegroup.com/cn/audits/) - [临床研究](https://www2.pqegroup.com/cn/clinical-research/) - [培训](https://www2.pqegroup.com/cn/training/) - 关于 - [关于我们](https://www2.pqegroup.com/cn/about/) - [企业社会责任](https://www2.pqegroup.com/cn/about/csr/) - 资源中心 - [新闻 & 新闻稿件](https://www2.pqegroup.com/cn/news/) - [网络研讨会](https://www2.pqegroup.com/cn/webinars/) - [博客](https://blog.pqegroup.com/zh-cn) - [加入我们](https://www2.pqegroup.com/cn/careers/) - [联系我们](https://www2.pqegroup.com/cn/contact-us/) [主页](https://www2.pqegroup.com/cn/) [博客](https://blog.pqegroup.com/) # **最新文章** [附录一 ![](https://blog.pqegroup.com/hubfs/banner%20INSIGHT-ANNEX%201%20%202022%20%20Compliance_1_1.jpg)](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-quality-and-compliance-update) 24 3月 2023 ## [2022年8月附录一更新 本文解读了于2022年8月发布的新版附录一。](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-quality-and-compliance-update) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=2022年8月附录一更新&url=https://blog.pqegroup.com/zh-cn/annex-1/annex-1-quality-and-compliance-update) [附录一 ![](https://blog.pqegroup.com/hubfs/From%20Reasoning%20to%20Specifics_banner%20sito-1.jpg)](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-reasoning-specifics) 20 3月 2023 ## [从论证到具体：新EU GMP附录1 更新后的欧盟GMP附录1终于在2022年8月出台。本文做了详细地解读。](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-reasoning-specifics) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=从论证到具体：新EU%20GMP附录1&url=https://blog.pqegroup.com/zh-cn/annex-1/annex-1-reasoning-specifics) [GxP合规 附录一 ![](https://blog.pqegroup.com/hubfs/Annex-1-Critical-Utilities-technical-qualification-GMP-compliance.jpg)](https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) 15 2月 2023 ## [关键公用工程的GMP合规性和新版附录一 了解新版附录一以及关键公用工程在更广泛的污染控制战略中的作用。](https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=关键公用工程的GMP合规性和新版附录一&url=https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) [附录一 ![](https://blog.pqegroup.com/hubfs/2020%20Annex%201%20draft%20new%20challenges%20for%20sterile%20manufacturers%20-%20ext.jpg)](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-2020-challenges-sterile-manufacturing) 14 2月 2023 ## [2020年附件1草案：无菌制造商面临的新挑战 带您解读新的附录一。](https://blog.pqegroup.com/zh-cn/annex-1/annex-1-2020-challenges-sterile-manufacturing) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=2020年附件1草案：无菌制造商面临的新挑战&url=https://blog.pqegroup.com/zh-cn/annex-1/annex-1-2020-challenges-sterile-manufacturing) ### 分类 - [GxP合规 (4)](https://blog.pqegroup.com/zh-cn/tag/gxp合规) - [医疗器械 (1)](https://blog.pqegroup.com/zh-cn/tag/医疗器械) - [女性科技(FemTech) (6)](https://blog.pqegroup.com/zh-cn/tag/女性科技femtech) - [工程 (1)](https://blog.pqegroup.com/zh-cn/tag/工程) - [药政事务 (1)](https://blog.pqegroup.com/zh-cn/tag/药政事务) - [计算机化系统验证和数据完整性 (5)](https://blog.pqegroup.com/zh-cn/tag/计算机化系统验证和数据完整性) - [调试、确认和验证 (CQV) (1)](https://blog.pqegroup.com/zh-cn/tag/调试-确认和验证-cqv) - [附录一 (4)](https://blog.pqegroup.com/zh-cn/tag/附录一) 查看所有话题 ### 注目記事Top 5 ### [领英](https://www.linkedin.com/company/pqe-group/) ![PQE Group](https://blog.pqegroup.com/hubfs/logo%20PQE%20Group%20+%20payoff-BLUE.svg) 自1998年起，PQE就通过了ISO 9001质量体系认证。 扫描关注PQE微信公众号。 ![PQE Group wechat weixin](https://blog.pqegroup.com/hs-fs/hubfs/PQE%20Group%20wechat%20weixin.jpg?width=127&height=127&name=PQE%20Group%20wechat%20weixin.jpg)   - 探索 - [加入PQE](https://www2.pqegroup.com/cn/careers/) - [全球分支](https://www2.pqegroup.com/cn/contact-us/#locations) - [关于](https://www2.pqegroup.com/cn/about/) - [博客](https://blog.pqegroup.com/zh-cn) - 相关链接 - [隐私政策](https://www2.pqegroup.com/privacy-notice/) - [Cookie政策](https://www2.pqegroup.com/cookie-policy/) - [组织模式](https://www2.pqegroup.com/cn/model-of-organization/) - [道德守则](https://www2.pqegroup.com/ethical-code/) English - [简体中文](https://blog.pqegroup.com/zh-cn/tag/附录一) - [Deutsch](https://blog.pqegroup.com/de/tag/annex-1) - [English](https://blog.pqegroup.com/tag/annex-1) - [Español - España](https://blog.pqegroup.com/es-es/tag/anexo-1) - [Español - México](https://blog.pqegroup.com/es-mx/tag/anexo-1) - [Français](https://blog.pqegroup.com/fr/tag/annexe-1) - [Polski](https://blog.pqegroup.com/pl/tag/annex-1) - [Português - Brasil](https://blog.pqegroup.com/pt-br/tag/anexo-1) - [Русский](https://blog.pqegroup.com/ru/tag/annex-1) - [עברית](https://blog.pqegroup.com/he/tag/annex-1) - [日本語](https://blog.pqegroup.com/ja/tag/annex-1) 切换语言 Copyright 2023 | 上海彼科意企业管理咨询有限公司 [LinkedIn](https://www.linkedin.com/company/pqe-group) [![twitter](https://blog.pqegroup.com/hubfs/twitter-w.png) Twitter](https://twitter.com/PQEGroup) [Facebook](https://www.facebook.com/PQEGroup/) [Instagram](https://www.instagram.com/lifeatpqe) [YouTube](https://www.youtube.com/c/PQEGroup) [Xing](https://www.xing.com/pages/pqegroup)